“Bitcoin and the Marijuana Industry” – BG Medical Technologies CEO Speaking at National Conference, Shareholders Invited
July 10 2014 - 8:37AM
Business Wire
BG Medical Technologies (OTC:RIGH) CEO, Angel Stanz has been
invited to discuss how digital media is changing the way patients
and entrepreneurs communicate about cannabis at “The State of
Marijuana” event to be held on July 26th in Hollywood, California
from 1pm to 9pm. This exclusive conversation with industry insiders
is a unique opportunity for shareholders, emerging entrepreneurs
and the public to discuss key topics with influential marijuana
companies.
Medical marijuana is currently legal in 23 states, two of which
have legalized cannabis for recreational use. With the imminent
reform on marijuana laws nationwide, many societal and economic
issues are being brought to the forefront. Mr. Stanz will join key
figures and opinion leaders across business, media, and academic
sectors to discuss the implications of the nation’s evolving
perspectives on cannabis and what the future will hold for this
controversial herb.
Mr. Stanz will participate on the Digital Media Panel discussing
BG Medical development projects involving Bitcoin, and the
potential impact of future payment systems on the industry. Panel
discussions will also include strategies for companies looking to
create online cannabis brands, digital marketing tools currently
available for cannabis companies, and how new cannabis
entrepreneurs can position themselves within the evolving
perception of cannabis in the mainstream media.
BudGenius is offering a limited time 20% discount to this
special event for all BG Medical Technologies shareholders and
BudGenius.com visitors. Eligible members are encouraged to visit
www.BudGenius.com to receive this discount and learn additional
event information.
About BG Medical Technologies
BG Medical Technologies is a medical marijuana company that
develops technology and research software for cannabis and natural
health solutions. The Company collects data through a network of
proprietary software, utilized by patients, by retail operators,
and by medical professionals. The Company's current flagship
product, BudGenius.com, is a social web platform connecting
cannabis patients to regionally available medicine that is paired
to their needs. The Company operates an analytical chemistry
laboratory designed for cannabis study, utilized to determine
potency and safety guidance for patients and medicine
manufacturers.
For more information please
visit:http://www.BudGenius.comhttp://www.BgMedTech.com
The foregoing press announcement contains forward-looking
statements that can be identified by such terminology such as
"believes," "expects," "potential," "plans," "suggests," "may,"
"should," "could," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results
to be materially different from any future results, performance or
achievements expressed or implied by such statements. In
particular, management's expectations could be affected by, among
other things, uncertainties relating to our success in completing
acquisitions, financing our operations, entering into strategic
partnerships, engaging management and other matters disclosed by us
in our public filings from time to time. Forward-looking statements
speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the
forward-looking statements are made.
BG Medical TechnologiesAngel Stanz, 855-723-3283Chief Executive
Officerpr@budgenius.com
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From May 2024 to Jun 2024
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Jun 2023 to Jun 2024